Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Bayer, Inxmed, Jazz, Nurix.
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Alloy, Ayrmid, Biolinerx, Gamida, Pep2tango, Primefour, Takeda, Transposon.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Amprion, Delve Bio, Fellow Health, Humancyte, Cnside Diagnostics, Veravas.